Trial Search Results

Engaging Patients to Help Achieve Increased Patient Choice and Engagement for AFib Stroke Prevention

A multi-center, randomized controlled 2-arm trial comparing the effectiveness of an innovative shared decision-making pathway and usual care for Atrial Fibrillation Stroke Prevention

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: The Cooper Health System

Stanford Investigator(s):

Intervention(s):

  • Behavioral: SDMT
  • Behavioral: Usual Care

Phase:

N/A

Eligibility


Inclusion Criteria:

   - ≥ 18 y/o

   - Non-valvular atrial fibrillation or atrial flutter (AFib)

   - CHA2DS2-VASc stroke score of:

      - Men: 1 or more

      - Women: 2 or more

   - Able to consent in English or Spanish (if resources allow) and follow study
   instructions

Exclusion Criteria:

   - Moderate to severe mitral stenosis

   - Mechanical valve replacement

   - Absolute contraindication to anticoagulation (Based on clinician judgment)

   - Indication for anticoagulation therapy for a condition other than atrial fibrillation

   - Left atrial appendage exclusion (by surgery or device placement)

   - At the clinical discretion of the investigator

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Katie DeSutter
650-725-4151
Recruiting